title: Chemotherapy at the End of Life: Factors of Prescription.
authors.affiliation: 1 Department of Medical Oncology, Institut de Cancérologie de Lorraine , Vandoeuvre-lès-Nancy, France .
authors.forename: Vincent
authors.initials: V
authors.lastname: Massard
authors.affiliation: 2 Unit of Biostatistics, Institut de Cancérologie de Lorraine , Vandoeuvre-lès-Nancy, France .
authors.forename: Julia
authors.initials: J
authors.lastname: Salleron
authors.affiliation: 1 Department of Medical Oncology, Institut de Cancérologie de Lorraine , Vandoeuvre-lès-Nancy, France .|3 Palliative Care Department, Institut de Cancérologie de Lorraine , Vandoeuvre-lès-Nancy, France .
authors.forename: Ivan
authors.initials: I
authors.lastname: Krakowski
authors.affiliation: 1 Department of Medical Oncology, Institut de Cancérologie de Lorraine , Vandoeuvre-lès-Nancy, France .
authors.forename: Thierry
authors.initials: T
authors.lastname: Conroy
authors.affiliation: 1 Department of Medical Oncology, Institut de Cancérologie de Lorraine , Vandoeuvre-lès-Nancy, France .
authors.forename: Béatrice
authors.initials: B
authors.lastname: Weber
mesh_terms: D000970:Antineoplastic Agents / Q000627:therapeutic use*; D003657:Decision Making; D005260:Female; D005602:France / Q000453:epidemiology; D006801:Humans; D008297:Male; D009369:Neoplasms / Q000188:drug therapy* / Q000401:mortality; D010166:Palliative Care; D015996:Survival Rate; D013727:Terminal Care
chemical_list: D000970:Antineoplastic Agents